Voyageur Pharmaceuticals Ltd. (OTCMKTS:VYYRF – Get Free Report) saw a significant increase in short interest in October. As of October 15th, there was short interest totaling 44,500 shares, an increase of 178.1% from the September 30th total of 16,000 shares. Based on an average trading volume of 71,093 shares, the short-interest ratio is currently 0.6 days.
Voyageur Pharmaceuticals Price Performance
OTCMKTS VYYRF opened at $0.02 on Friday. Voyageur Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $1.03. The business has a fifty day simple moving average of $0.12 and a 200 day simple moving average of $0.10.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd. is a Canadian pharmaceutical company focused on developing, manufacturing and commercializing contrast media used in medical imaging. Its products are designed to help healthcare professionals visualize internal organs and structures during diagnostic procedures.
The company’s primary focus is on barium sulfate and iodinated contrast media. Barium sulfate products are used in gastrointestinal imaging, while iodinated agents are used in procedures such as computed tomography and other X-ray-based examinations.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
